ENTBF (Entheon Biomedical) Retained Earnings: $-14.95 Mil (As of Feb. 2026)


What is Entheon Biomedical Retained Earnings?

Entheon Biomedical ENTBF Retained Earnings is $-14.95 Mil as of Feb. 2026. The stock has 2 warning signs investors should review.

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Entheon Biomedical's retained earnings for the quarter that ended in Feb. 2026 was $-14.95 Mil.

Entheon Biomedical's quarterly retained earnings increased from Aug. 2025 ($-15.18 Mil) to Nov. 2025 ($-14.85 Mil) but then declined from Nov. 2025 ($-14.85 Mil) to Feb. 2026 ($-14.95 Mil).

Entheon Biomedical's annual retained earnings increased from Nov. 2023 ($-15.55 Mil) to Nov. 2024 ($-14.98 Mil) and increased from Nov. 2024 ($-14.98 Mil) to Nov. 2025 ($-14.85 Mil).


Entheon Biomedical  (OTCPK:ENTBF) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


Entheon Biomedical Retained Earnings Historical Data

* Premium members only.

The historical data trend for Entheon Biomedical's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Entheon Biomedical Retained Earnings Chart

Entheon Biomedical Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Nov21 Nov22 Nov23 Nov24 Nov25
Retained Earnings
Get a 7-Day Free Trial Premium Member Only -10.78 -16.06 -15.55 -14.98 -14.85

Entheon Biomedical Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -14.74 -15.07 -15.18 -14.85 -14.95

Entheon Biomedical Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Frequently Asked Questions Learn more about Retained Earnings →
What does a Retained Earnings of $-14.95 Mil mean?
Entheon Biomedical (ENTBF) has a Retained Earnings of $-14.95 Mil as of Feb. 2026. Retained earnings is the amount of net income not issued to shareholders. View historical data on Entheon Biomedical and its competitors.
Is Entheon Biomedical's Retained Earnings too high?
Entheon Biomedical's current Retained Earnings is $-14.95 Mil.
How does Entheon Biomedical's Retained Earnings compare to VRTX and REGN?
Entheon Biomedical's Retained Earnings of $-14.95 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Retained Earnings for a Biotechnology company?
A good Retained Earnings depends on the Biotechnology industry context. However, Retained Earnings should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Retained Earnings mean?
A high Retained Earnings can signal that a stock is expensive relative to its fundamentals. Retained earnings is the amount of net income not issued to shareholders. View historical data on Entheon Biomedical and its competitors. Entheon Biomedical's current Retained Earnings is $-14.95 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Entheon Biomedical stock overvalued right now?
Entheon Biomedical (ENTBF) has a current Retained Earnings of $-14.95 Mil. The current Retained Earnings is $-14.95 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Retained Earnings calculated?
Retained Earnings is calculated from a company's financial statements. For Entheon Biomedical (ENTBF), the current Retained Earnings is $-14.95 Mil as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Entheon Biomedical Business Description

Other Exchanges 1XU:GermanyENBI.X:Canada
Address 999 West Broadway Street, Suite 720, Vancouver, BC, CAN, V5Z 1K5
Entheon Biomedical Corp is a biotechnology research and development company focused on treating addiction and substance use disorders.